Sales of medical plastic in Türkiye are estimated to be valued at US$ 217.5 million in 2023 and US$ 328.9 million by 2033. Over the forecast period, demand for medical plastic in Türkiye is expected to increase at a CAGR of 4.2%.
| Attributes | Key Insights |
|---|---|
| Base Value 2022 | US$ 209.7 million |
| Estimated Türkiye Medical Plastic Industry Size (2023) | US$ 217.5 million |
| Projected Türkiye Medical Plastic Revenue (2033) | US$ 328.9 million |
| Value-based CAGR (2023 to 2033) | 4.2% |
As global healthcare spending rises, so does the need for medical equipment and technologies. Plastics are frequently utilized in the production of medical equipment owing to their biocompatibility, flexibility, and durability.
As medical technology continues to progress, more advanced and intricate medical devices are being created. Plastics are essential to these advancements because of their adaptability and capacity to fulfill particular performance demands.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Industry to Expand Around 1.5X through 2033
Türkiye's medical plastic industry is predicted to expand over 1.5X through 2033, amid an increase in expected CAGR compared to the historical one. Advancements in medical plastics technologies, improved fuel efficiency, and the rising focus on sustainable power solutions contribute to the positive trajectory of the industry in Türkiye. By 2033, the total industry revenue is set to reach US$ 328.9 million.
Principal Consultant
The medical plastic industry in Türkiye attained a valuation of US$ 209.7 million in 2022. In the forecast period, sales of medical plastic in Türkiye are projected to rise at a 4.2% CAGR. The medical plastic industry in Türkiye is poised for significant growth, driven by several factors that reflect the country's evolving healthcare landscape and industrial developments.
With a rising focus on healthcare infrastructure and technological advancements, the demand for medical devices and equipment extensively utilizing medical plastics is expected to surge. Türkiye's growing population and increasing healthcare expenditure would contribute to business expansion.
As the country witnesses economic growth and urbanization, there is a heightened demand for modern medical facilities and equipment, creating a favorable environment for the medical plastic industry. The rising middle class and improving living standards can drive the demand for advanced medical treatments and devices, further propelling the need for medical plastics.
Technological innovations in the medical field are pivotal in the industry outlook. Ongoing advancements in medical technology have led to the development of sophisticated devices and diagnostic equipment, several of which rely on specialized medical plastics for their production.
The future outlook for the Türkiye medical plastic industry is optimistic, with an anticipated valuation of US$ 328.9 million in 2033. This growth is driven by the increasing demand for sterilization and infection control, which play crucial roles in the medical sector.
Sterilization and infection control play significant roles in the medical field to ensure patient safety and prevent the spread of diseases. However, a handful of medical devices and appliances are difficult or impractical to sterilize effectively for reuse. This drives the demand for single-use and disposable plastic products, such as syringes, catheters, gloves, masks, and surgical drapes.
The growing trend of self-administration of drugs and the development of new drug delivery technologies are creating significant opportunities in the medical plastic industry. As patients increasingly take an active role in their healthcare, there is a rising demand for user-friendly and convenient drug delivery systems.
This trend has led to the development of innovative medical devices, such as auto-injectors, inhalers, and wearable injectors, which allow patients to self-administer medications at home or on the go.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
As people age, their healthcare requirements tend to increase, leading to a higher demand for medical devices and equipment. These devices commonly use medical plastics because of their durability, adaptability, and cost-effectiveness.
People suffering from chronic health conditions that necessitate ongoing care are in greater need of medical supplies such as syringes and catheters, predominantly made from plastic materials. Medical technological developments have increased the use of minimally invasive procedures that heavily rely on disposable plastic tools and instruments. The medical plastic industry will continue to expand as age-related illnesses surge.
As healthcare systems in Türkiye strive to improve patient care and outcomes, there is a growing need for advanced medical devices and equipment. With their versatility, durability, and cost-effectiveness, medical plastic is preferred in the manufacturing of several healthcare products, such as syringes, catheters, surgical instruments, and drug delivery systems.
Medical plastic offers advantages such as biocompatibility, sterility, and chemical resistance, which are crucial for ensuring patient safety and preventing infections. The increased emphasis on developing cutting-edge medical devices and improving patient care drives the demand for medical plastics.
Advances in medical technology and innovations in plastic materials have significantly driven demand in the medical plastic industry. The healthcare industry is experiencing a paradigm shift with the introduction of cutting-edge medical technologies and devices that have revolutionized patient care, diagnosis, and treatment.
Innovations in plastic manufacturing techniques, such as injection molding and 3D printing, have further expanded the possibilities for creating customized medical devices and components. The introduction of plastic-based endoscopes, catheters, and surgical equipment has enabled less intrusive operations, reducing patient trauma, speeding up recovery, and enhancing results.
The medical industry is highly regulated to ensure patient safety. Compliance with strict regulations and standards can pose challenges and increase the cost of development & production for medical plastic manufacturers.
The regulations often require extensive testing and documentation, increasing the time and cost of bringing new medical plastic products to industry. The rigorous approval processes can lead to product launch delays and hinder industry innovation.
The manufacturing of medical plastics is significantly dependent on a variety of raw materials, including polyvinyl chloride (PVC), polyethylene (PE), polypropylene (PP), and polystyrene (PS). These basic materials are essential in the production of healthcare-related equipment, packaging, and medical devices. When the cost of raw materials increases unexpectedly, it becomes challenging for companies to maintain stable product prices.
The uncertainty caused by fluctuating raw material prices creates a challenging business environment for medical plastic manufacturers. Forecasting costs accurately and planning production & inventory management efficiently becomes more difficult. This can lead to supply chain disruptions, delayed deliveries, and reduced customer satisfaction.
The below section highlights the projected CAGR of key segments, including end-use and plastic type. Demand for medical cables and connectors is projected to surge at a CAGR of 4.8% through 2033. The polyvinyl chloride (PVC) segment is predicted to register a CAGR of 2.6% between 2023 and 2033.
| End-use | Medical Cables and Connectors |
|---|---|
| Projected CAGR (2023 to 2033) | 4.8% |
Ongoing technological advancements in the healthcare industry have led to the development of sophisticated medical devices and equipment. These advanced devices often require specialized cables and connectors made from high-performance medical plastics to ensure reliable and precise functionality.
The demand for medical cables and connectors has surged with an increasing emphasis on patient monitoring and continuous healthcare assessment. These components transmit data between medical sensors, devices, and monitoring systems.
Medical plastics, including specialized formulations such as thermoplastics and thermoplastic elastomers, offer the necessary durability and reliability for applications. The demand for medical cables and connectors is projected to rise at a CAGR of 4.8% through 2033.
| Plastic Type | Polyvinyl Chloride (PVC) |
|---|---|
| Projected CAGR (2023 to 2033) | 2.6% |
PVC is known for its excellent chemical resistance, durability, and cost-effectiveness. In the medical field, PVC is set to be extensively used to produce medical devices such as intravenous (IV) tubing, blood bags, catheters, and flexible medical containers.
PVC's transparency is crucial for applications like IV bags, where visual monitoring of fluid levels is essential. PVC's compatibility with sterilization methods, including gamma radiation and ethylene oxide, can help ensure the safety and sterility of medical devices. Additionally, PVC is expected to be widely adopted for its fire resistance, a critical feature in healthcare settings.
Türkiye's medical plastic industry is fragmented, with leading players accounting for around 45% to 50% of the total share. Celanese Corporation, Trinseo PLC, Ensinger Group, BASF SE, Dow Chemical Company, and Saudi Basic Industries Corp (SABIC) are the leading manufacturers and suppliers of medical plastic in Türkiye.
Key medical plastics companies in Türkiye are investing in continuous research to offer new products and increase their production capacity to meet end-user demand. They are also inclined toward adopting strategies to strengthen their footprint, including partnerships, mergers, acquisitions, and facility expansions.
Recent Developments in Türkiye Medical Plastic Industry
| Attribute | Details |
|---|---|
| Estimated Size (2023) | US$ 217.5 million |
| Projected Value (2033) | US$ 328.9 million |
| Anticipated Growth Rate (2023 to 2033) | 4.2% |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Value (US$ million) and Volume (tons) |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Plastic Type, End-use |
| Key Companies Profiled | Celanese Corporation; Trinseo PLC; Ensinger Group; BASF SE; The Dow Chemical Company; Saudi Basic Industries Corp (SABIC); DuPont de Nemours, Inc.; Arkema Group; Evonik Industries; Eastman Chemical Company; LyondellBasell Industries N.V.; Hanwha Group; Covestro AG; Solvay SA; EMCO Industrial Plastic Inc.; The Lubrizol Corporation; Trelleborg Group; Teknor Apex; Spartech LLC; Raumedic AG; HMC Polymers Company Limited; Tekni-Plex, Inc. |
Türkiye industry is set to reach US$ 217.5 million in 2023.
Demand in Türkiye is slated to expand at a 4.2% CAGR through 2033.
The target industry is set to reach US$ 328.9 million in 2033.
Celanese Corporation, Trinseo PLC, and Ensinger Group are key players.
The medical cables and connectors segment is expected to garner a significant value share by 2023.
1. Executive Summary
1.1. Industry Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Industry Overview
2.1. Industry Coverage / Taxonomy
2.2. Industry Definition / Scope / Limitations
3. Key Industry Trends
3.1. Key Trends Impacting the Industry
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Strategic Promotional Strategies
5. Industry Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
5.1. Historical Industry Volume (tons) Analysis, 2018 to 2022
5.2. Current and Future Industry Volume (tons) Projections, 2023 to 2033
5.3. Y-o-Y Growth Trend Analysis
6. Industry - Pricing Analysis
6.1. Regional Pricing Analysis By Plastic Type
6.2. Average Pricing Analysis Benchmark
7. Industry Demand (in Value or Size in US$ million) Analysis 2018 to 2022 and Forecast, 2023 to 2033
7.1. Historical Industry Value (US$ million) Analysis, 2018 to 2022
7.2. Current and Future Industry Value (US$ million) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Industry Background
8.1. Macro-Economic Factors
8.1.1. GDP Growth Outlook
8.1.2. Chemical industry Overview
8.1.3. Manufacturing Value-Added
8.1.4. Industry Value Added
8.1.5. Parent Industry Outlook
8.1.6. Other Macro-Economic Factors
8.2. Forecast Factors - Relevance and Impact
8.2.1. Top Companies Historical Growth
8.2.2. GDP Growth forecast
8.2.3. Manufacturing Industry forecast
8.2.4. Urbanization Growth Outlook
8.2.5. Business Climate
8.2.6. Covid-19 Impact Assessment
8.2.7. End-use Industry Growth Outlook
8.3. Value Chain
8.3.1. Product Manufacturers
8.3.2. End-users
8.3.3. Avg. Profitability Margins
8.4. COVID-19 Crisis – Impact Assessment
8.4.1. Current Statistics
8.4.2. Short-Mid-Long Term Outlook
8.4.3. Likely Rebound
8.5. Industry Dynamics
8.5.1. Drivers
8.5.2. Restraints
8.5.3. Opportunity Analysis
8.6. Supply Demand Analysis
8.7. Key Regulations and Certifications
8.8. Production Process Overview
8.9. Trade Scenario
9. Industry Analysis 2018 to 2022 and Forecast 2023 to 2033 , By Plastic Type
9.1. Introduction / Key Findings
9.2. Historical Industry Size (US$ million) and Volume Analysis By Plastic Type, 2018 to 2022
9.3. Current and Future Industry Size (US$ million) and Volume Analysis and Forecast By Plastic Type, 2023 to 2033
9.3.1. Polyvinyl Chloride (PVC)
9.3.2. Thermoplastic Elastomer (TPE)
9.3.2.1. Thermoplastic Elastomer Styrenics (TPE-S)
9.3.2.2. Thermoplastic Elastomer Vulcanizates (TPE-V)
9.3.3. Polyethylene (PE)
9.3.4. Polycarbonate (PC)
9.3.5. Polypropylene (PP)
9.3.6. Polyethylene Terephthalate (PET)
9.3.7. Polyamides
9.3.8. Thermoplastic Polyurethane (TPU)
9.3.9. Polymethyl Methacrylate
9.3.10. Acrylonitrile Butadiene Styrene (ABS)
9.3.11. Silicone Rubber
9.3.11.1. Liquid Silicone Rubber
9.3.11.2. High Consistency Rubber
9.3.11.3. Room Temperature Vulcanizing (RTV) Silicone
9.3.11.4. Silicone Adhesives
9.3.12. Others
9.4. Industry Attractiveness Analysis By Plastic Type
10. Industry Analysis 2018 to 2022 and Forecast 2023 to 2033 , By End-use
10.1. Introduction / Key Findings
10.2. Historical Industry Size (US$ million) and Volume Analysis By End-use, 2018 to 2022
10.3. Current and Future Industry Size (US$ million) and Volume Analysis and Forecast By End-use, 2023 to 2033
10.3.1. Medical Parts and Components
10.3.1.1. Dropper Bulbs
10.3.1.2. Drip Chambers
10.3.1.3. Gaskets and Stoppers
10.3.1.4. Orthopedics
10.3.1.5. Blood Collection Chambers
10.3.1.6. Medical Containers
10.3.1.7. Others
10.3.2. Tubing
10.3.2.1. Catheter Tubing
10.3.2.2. Drug Delivery
10.3.2.3. Gas Supply
10.3.2.4. Peristaltic Pump
10.3.2.5. Oxygen Tubing
10.3.2.6. Blood Transport and Delivery Tubing
10.3.2.7. Others
10.3.3. Film and Bags
10.3.3.1. Biopharmaceutical Storage
10.3.3.2. Saline Bags
10.3.3.3. Waste Bags
10.3.3.4. Others
10.3.4. Surgical Tools
10.3.4.1. Scalpels
10.3.4.2. Forceps
10.3.4.3. Scissors
10.3.4.4. Others
10.3.5. Medical Cables and Connectors
10.3.6. Diagnostic Equipment
10.3.7. Prosthetics
10.3.8. Others
10.4. Industry Attractiveness Analysis By End-use
11. Industry Structure Analysis
11.1. Industry Analysis by Tier of Companies
11.2. Industry Concentration
11.3. Share Analysis of Top Players
11.4. Production Capacity Analysis
11.5. Presence Analysis
11.5.1. By Category-C Footprint of Players
11.5.2. By Regional Footprint of Players
11.5.3. By Channel Footprint of Players
12. Competition Analysis
12.1. Competition Dashboard
12.2. Competition Benchmarking
12.3. Competition Deep Dive
12.3.1. Celanese Corporation
12.3.1.1. Overview
12.3.1.2. Product Portfolio
12.3.1.3. Profitability by Segments (Product/Channel/Region)
12.3.1.4. Sales Footprint
12.3.1.5. Strategy Overview
12.3.2. Trinseo PLC
12.3.3. Ensinger Group
12.3.4. BASF SE
12.3.5. The Dow Chemical Company
12.3.6. Saudi Basic Industries Corp (SABIC)
12.3.7. DuPont de Nemours, Inc.
12.3.8. Arkema Group
12.3.9. Evonik Industries
12.3.10. Eastman Chemical Company
12.3.11. LyondellBasell Industries N.V.
12.3.12. Hanwha Group
12.3.13. Covestro AG
12.3.14. Solvay SA
12.3.15. EMCO Industrial Plastic Inc.
12.3.16. The Lubrizol Corporation
12.3.17. Trelleborg Group
12.3.18. Teknor Apex
12.3.19. Spartech LLC
12.3.20. Raumedic AG
12.3.21. HMC Polymers Company Limited
12.3.22. Tekni-Plex, Inc.
13. Assumptions and Acronyms Used
14. Research Methodology
Explore Chemicals & Materials Insights
View Reports
Medical Plastic Industry Analysis in Türkiye
